Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

The Neuropeptides of Ocular Immune Privilege, α-MSH and NPY, Suppress Phagosome Maturation in Macrophages.

Benque IJ, Xia P, Shannon R, Ng TF, Taylor AW.

Immunohorizons. 2018 Nov;2(10):314-323. doi: 10.4049/immunohorizons.1800049.

2.

The neuropeptides α-MSH and NPY modulate phagocytosis and phagolysosome activation in RAW 264.7 cells.

Phan TA, Taylor AW.

J Neuroimmunol. 2013 Jul 15;260(1-2):9-16. doi: 10.1016/j.jneuroim.2013.04.019. Epub 2013 May 17.

3.

Retinal Pigment Epithelial Cell Line Suppression of Phagolysosome Activation.

Taylor AW, Dixit S, Yu J.

Int J Ophthalmol Eye Sci. 2015 Jan 29;Suppl 2(1):1-6.

4.

Retinal Pigment Epithelial Cells Suppress Phagolysosome Activation in Macrophages.

Wang E, Choe Y, Ng TF, Taylor AW.

Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):1266-1273. doi: 10.1167/iovs.16-21082.

5.

Negative regulators that mediate ocular immune privilege.

Taylor AW, Ng TF.

J Leukoc Biol. 2018 Feb 12. doi: 10.1002/JLB.3MIR0817-337R. [Epub ahead of print] Review.

PMID:
29431864
6.
7.

Neuropeptide Y inhibits spontaneous alpha-melanocyte-stimulating hormone (alpha-MSH) release via a Y(5) receptor and suppresses thyrotropin-releasing hormone-induced alpha-MSH secretion via a Y(1) receptor in frog melanotrope cells.

Galas L, Tonon MC, Beaujean D, Fredriksson R, Larhammar D, Lihrmann I, Jegou S, Fournier A, Chartrel N, Vaudry H.

Endocrinology. 2002 May;143(5):1686-94.

PMID:
11956150
8.

Alpha-melanocyte stimulating hormone (α-MSH) is a post-caspase suppressor of apoptosis in RAW 264.7 macrophages.

Taylor AW.

PLoS One. 2013 Aug 29;8(8):e74488. doi: 10.1371/journal.pone.0074488. eCollection 2013.

9.

Relationship between alpha-melanocyte-stimulating hormone- and neuropeptide Y-containing neurons in the goldfish hypothalamus.

Kojima K, Amiya N, Kamijo M, Kageyama H, Uchiyama M, Shioda S, Matsuda K.

Gen Comp Endocrinol. 2010 Jul 1;167(3):366-72. doi: 10.1016/j.ygcen.2009.12.004. Epub 2009 Dec 11.

PMID:
20005228
10.

Neuropeptides, including neuropeptide Y and melanocortins, mediate lipolysis in murine adipocytes.

Bradley RL, Mansfield JP, Maratos-Flier E.

Obes Res. 2005 Apr;13(4):653-61.

12.
13.

Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study.

Baltazi M, Katsiki N, Savopoulos C, Iliadis F, Koliakos G, Hatzitolios AI.

Am J Cardiovasc Dis. 2011;1(1):48-59. Epub 2011 May 20.

14.

Ocular immunosuppressive microenvironment.

Taylor AW.

Chem Immunol Allergy. 2007;92:71-85. Review.

PMID:
17264484
15.

Hypothalamic interactions between neuropeptide Y, agouti-related protein, cocaine- and amphetamine-regulated transcript and alpha-melanocyte-stimulating hormone in vitro in male rats.

Dhillo WS, Small CJ, Stanley SA, Jethwa PH, Seal LJ, Murphy KG, Ghatei MA, Bloom SR.

J Neuroendocrinol. 2002 Sep;14(9):725-30.

PMID:
12213133
16.

Mechanisms by which the orexigen NPY regulates anorexigenic α-MSH and TRH.

Cyr NE, Toorie AM, Steger JS, Sochat MM, Hyner S, Perello M, Stuart R, Nillni EA.

Am J Physiol Endocrinol Metab. 2013 Mar 15;304(6):E640-50. doi: 10.1152/ajpendo.00448.2012. Epub 2013 Jan 15.

17.

The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy.

Taylor AW, Kitaichi N.

Brain Behav Immun. 2008 Jul;22(5):639-46. doi: 10.1016/j.bbi.2007.11.001. Epub 2008 Jan 2.

18.

Neuropeptide Y expression in cutaneous melanoma.

Gilaberte Y, Roca MJ, Garcia-Prats MD, Coscojuela C, Arbues MD, Vera-Alvarez JJ.

J Am Acad Dermatol. 2012 Jun;66(6):e201-8. doi: 10.1016/j.jaad.2011.02.015. Epub 2011 May 26.

PMID:
21620518
19.

Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor.

Taylor AW, Yee DG, Streilein JW.

Invest Ophthalmol Vis Sci. 1998 Jul;39(8):1372-8.

PMID:
9660485
20.

The alpha-melanocyte stimulating hormone induces conversion of effector T cells into treg cells.

Taylor AW, Lee DJ.

J Transplant. 2011;2011:246856. doi: 10.1155/2011/246856. Epub 2011 Sep 15.

Supplemental Content

Support Center